EnGeneIC
PrivateLast Round
Crowdfunding
Aug 1, 2021
Total Funding Raised
$17.17M
Company Overview
EnGeneIC operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was a Crowdfunding round in August 2021.
EnGeneIC is a clinical-stage biopharmaceutical company that has developed a proprietary nanocell technology for the targeted delivery of chemotherapeutics and functional nucleic acids for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EnGeneIC Comparables
Compare EnGeneIC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vaxiion Therapeutics | 79% | |
| Vector Bioscience Cambridge | 75% | |
| Actym Therapeutics | 69% |
For institutional investors. Book with your work email.
EnGeneIC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Aug 1, 2021 | ||||
| Series B | Jan 6, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EnGeneIC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GRT Capital Partners | Series B |
| Foley & Lardner LLP | Series B |
| VentureCrowd | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 70% MoM.
- Oct 13, 2025
Grew 18% QoQ, from 44 to 52 employees.
For institutional investors. Book with your work email.
EnGeneIC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EnGeneIC's valuation, stock price, and market status.
Is EnGeneIC a public or private company?
EnGeneIC is a private company.
What is the current stock price of EnGeneIC?
EnGeneIC is a private company, so its shares have no public market price. Caplight tracks EnGeneIC's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EnGeneIC worth (valuation)?
Valuation information for EnGeneIC is not publicly available.
Can I buy EnGeneIC stock?
EnGeneIC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EnGeneIC's last funding round?
EnGeneIC's most recent funding round was Crowdfunding on August 1, 2021.
Who are the main investors in EnGeneIC?
Key investors in EnGeneIC include GRT Capital Partners.
Will EnGeneIC IPO soon?
No public IPO plans have been announced for EnGeneIC.
How can I track EnGeneIC secondary market activity?
Caplight tracks bids, offers, and trades in EnGeneIC's shares on secondary markets.